Tyra Biosciences, Inc. TYRA Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Tyra Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The official record: Tyra Biosciences, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tyra Biosciences, Inc.'s total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tyra Biosciences, Inc.'s total current liabilities?
- Tyra Biosciences, Inc. (TYRA) reported total current liabilities of $19.26M in Q1 2026.
- How has Tyra Biosciences, Inc.'s total current liabilities changed year-over-year?
- Tyra Biosciences, Inc.'s total current liabilities increased by 35.2% year-over-year, from $14.25M to $19.26M.
- What is the long-term trend for Tyra Biosciences, Inc.'s total current liabilities?
- Over 5 years (2020 to 2025), Tyra Biosciences, Inc.'s total current liabilities has grown at a 57.7% compound annual growth rate (CAGR), from $1.86M to $18.09M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.